GE HealthCare Q1 revenue beats but full-year EPS guidance disappoints

StockStory··Read original
3▲1 ▼2Impact / 5
Summary · why it matters

GE HealthCare reported first-quarter revenues of $5.13 billion, up 7.4% year on year and exceeding analyst expectations by 2.1%, but the company significantly missed full-year EPS guidance and quarterly EPS estimates. The stock fell 11.1% since the report and now trades at $60.91. Among the 37 healthcare equipment and supplies stocks tracked, aggregate revenues beat consensus by 2.3% while next-quarter revenue guidance came in 1.3% below estimates. STAAR Surgical posted the strongest performance with revenues of $93.52 million, up 120% year on year and beating estimates by 20.8%, while Stryker was the weakest with revenues of $6.02 billion, up 2.6% but missing expectations by 5%.

Impact on assets 5

Biotech & Genomic Medicine▼
Aging Population▲
Robotics & Physical AI▼